ST. LOUIS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- . (NYSE: SF) today reported selected operating results for August 31, 2026, to ...
RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid ...
Fintel reports that on 23 September 2026, Stifel upgraded their outlook for Microsoft (LSE:0QYP) from Hold to Buy. This upgrade follows a prior action on 4 September 2026, when Stifel maintained its ...
Fintel reports that on 17 September 2026, STIFEL EUROPE upgraded their outlook for Eutelsat Communications (WBAG:ETL) from Sell to Hold. This rating action follows a prior action on 12 May 2026, when ...
Shaun White's exciting halfpipe league traveled to Cardrona to test an anti-spin-to-win rule, a new team-based format, and more.
While Acadia Pharmaceuticals’ candidate has missed the main goal of a Phase 2 trial, the company is still moving forward with the anti-psychosis candidate in Alzheimer’s disease as well as Lewy body ...
Q2 FY2027 earnings call recap: record QNX revenue, Alloy Kore & Uber design wins, raised guidance, and key risks.
Trotz eines Tageshochs bei 509,44 Dollar konnte sich die Microsoft-Aktie auch am gestrigen Mittwoch nicht von der 500-Dollar-Marke lösen.
Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory, and related financial services. It operates through the following segments: Global Wealth ...
Stifel analyst Brad Reback upgraded Microsoft from Hold to Buy with a $575 target on September 23, citing accelerating Azure growth and Copilot engagement at par with Outlook and Teams. Shares closed ...
Drug developer City ​Therapeutics ‌filed for an initial public offering ‌in ​the ⁠US on ⁠Thursday. The Cambridge, ...
Brad Reback, the Managing Director of the global wealth management and investment banking firm Stifel Nicolaus, has predicted that Microsoft stock would rise above the $500 level and reach a new high ...